Found 4 hits for monomerid = 50072196 Target/Host
(Institution) | Ligand | Target/Host
Links | Ligand
Links | Trg + Lig
Links | Ki
nM | ΔG°
kcal/mole | IC50
nM | Kd
nM | EC50/IC50
nM | koff
s-1 | kon
M-1s-1 | pH | Temp
°C |
|---|
cAMP-specific 3',5'-cyclic phosphodiesterase 4A
(Homo sapiens (Human)) | BDBM50072196
(2-[2,4-Bis-(3,5-bis-cyclopropylmethoxy-phenyl)-6-m...)Show SMILES COc1cc2c(nc(nc2cc1OCCO)-c1cc(OCC2CC2)cc(OCC2CC2)c1)-c1cc(OCC2CC2)cc(OCC2CC2)c1 Show InChI InChI=1S/C39H44N2O7/c1-43-36-18-34-35(19-37(36)44-11-10-42)40-39(29-14-32(47-22-26-6-7-26)17-33(15-29)48-23-27-8-9-27)41-38(34)28-12-30(45-20-24-2-3-24)16-31(13-28)46-21-25-4-5-25/h12-19,24-27,42H,2-11,20-23H2,1H3 | PDB
MMDB
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
| CHEMBL
PC cid
PC sid
UniChem
Similars
| PubMed
| n/a | n/a | 1.40E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Pharma AG
Curated by ChEMBL
| Assay Description
Evaluated for its ability to inhibit PDE4A. |
Bioorg Med Chem Lett 8: 2891-6 (1999)
BindingDB Entry DOI: 10.7270/Q2PG1QVX |
More data for this
Ligand-Target Pair | |
cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A/3B
(Homo sapiens (Human)) | BDBM50072196
(2-[2,4-Bis-(3,5-bis-cyclopropylmethoxy-phenyl)-6-m...)Show SMILES COc1cc2c(nc(nc2cc1OCCO)-c1cc(OCC2CC2)cc(OCC2CC2)c1)-c1cc(OCC2CC2)cc(OCC2CC2)c1 Show InChI InChI=1S/C39H44N2O7/c1-43-36-18-34-35(19-37(36)44-11-10-42)40-39(29-14-32(47-22-26-6-7-26)17-33(15-29)48-23-27-8-9-27)41-38(34)28-12-30(45-20-24-2-3-24)16-31(13-28)46-21-25-4-5-25/h12-19,24-27,42H,2-11,20-23H2,1H3 | PDB
MMDB
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| PubMed
| n/a | n/a | 7.80E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Pharma AG
Curated by ChEMBL
| Assay Description
Evaluated for its ability to inhibit PDE3. |
Bioorg Med Chem Lett 8: 2891-6 (1999)
BindingDB Entry DOI: 10.7270/Q2PG1QVX |
More data for this
Ligand-Target Pair | |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D
(Homo sapiens (Human)) | BDBM50072196
(2-[2,4-Bis-(3,5-bis-cyclopropylmethoxy-phenyl)-6-m...)Show SMILES COc1cc2c(nc(nc2cc1OCCO)-c1cc(OCC2CC2)cc(OCC2CC2)c1)-c1cc(OCC2CC2)cc(OCC2CC2)c1 Show InChI InChI=1S/C39H44N2O7/c1-43-36-18-34-35(19-37(36)44-11-10-42)40-39(29-14-32(47-22-26-6-7-26)17-33(15-29)48-23-27-8-9-27)41-38(34)28-12-30(45-20-24-2-3-24)16-31(13-28)46-21-25-4-5-25/h12-19,24-27,42H,2-11,20-23H2,1H3 | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| PubMed
| n/a | n/a | 8.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Pharma AG
Curated by ChEMBL
| Assay Description
Evaluated for its ability to inhibit PDE4D. |
Bioorg Med Chem Lett 8: 2891-6 (1999)
BindingDB Entry DOI: 10.7270/Q2PG1QVX |
More data for this
Ligand-Target Pair | |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B
(RAT) | BDBM50072196
(2-[2,4-Bis-(3,5-bis-cyclopropylmethoxy-phenyl)-6-m...)Show SMILES COc1cc2c(nc(nc2cc1OCCO)-c1cc(OCC2CC2)cc(OCC2CC2)c1)-c1cc(OCC2CC2)cc(OCC2CC2)c1 Show InChI InChI=1S/C39H44N2O7/c1-43-36-18-34-35(19-37(36)44-11-10-42)40-39(29-14-32(47-22-26-6-7-26)17-33(15-29)48-23-27-8-9-27)41-38(34)28-12-30(45-20-24-2-3-24)16-31(13-28)46-21-25-4-5-25/h12-19,24-27,42H,2-11,20-23H2,1H3 | PDB
UniProtKB/SwissProt
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| PubMed
| n/a | n/a | 2.20E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Pharma AG
Curated by ChEMBL
| Assay Description
Evaluated for its ability to inhibit PDE4B. |
Bioorg Med Chem Lett 8: 2891-6 (1999)
BindingDB Entry DOI: 10.7270/Q2PG1QVX |
More data for this
Ligand-Target Pair | |
Search and Browse
